This inventor holds 1 USPTO granted patent. Top assignee: Animal, Plant and Fisheries Quarantine and Inspection Agency. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Chang-Hee Kweon: Innovator in Transmissible Spongiform Encephalopathy Research
Introduction
Chang-Hee Kweon is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of transmissible spongiform encephalopathy (TSE) research. His innovative work focuses on the preparation of cells that are susceptible to TSE, which has important implications for diagnosis and therapeutic development.
Latest Patents
Chang-Hee Kweon holds a patent for a method of preparing cells susceptible to transmissible spongiform encephalopathy. This patent, titled "Method of preparing cells susceptible to transmissible spongiform encephalopathy and the creation of TSE persistently infected cells," discloses a method that allows for the efficient use of these cells in TSE diagnosis, etiology studies, and the development of novel therapeutics. He has 1 patent to his name.
Career Highlights
Chang-Hee Kweon is affiliated with the Animal, Plant and Fisheries Quarantine and Inspection Agency. His work at this agency emphasizes the importance of research in animal health and safety. His contributions have been vital in advancing the understanding of TSE and its implications for both animal and human health.
Collaborations
Chang-Hee Kweon has collaborated with notable colleagues, including Hyun-Joo Shon and Yi-Seok Joo. These collaborations have further enriched his research and have contributed to the advancement of knowledge in the field of transmissible spongiform encephalopathy.
Conclusion
Chang-Hee Kweon's innovative work in the field of transmissible spongiform encephalopathy has made a significant impact on research and diagnostics. His contributions continue to pave the way for advancements in understanding and treating this complex disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile